Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
September 13, 2021
Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in Germany
David Krug, Markus Hecht, Nadja Ebert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 26, 2023
Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy
Jiaqi Fan, Anne Adams, Noëlle Sieg, et al.
Clinical Nuclear Medicine
|
January 14, 2025
The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor Relapse
Garry S Ceccon, Jan-Michael Werner, Maximilian I Ruge, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 5, 2020
Treatment Monitoring of Immunotherapy and Targeted Therapy Using <sup>18</sup>F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences
Norbert Galldiks, Diana S Y Abdulla, Matthias Scheffler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2019
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
Michael Fuchs, Helen Goergen, Carsten Kobe, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 15, 2017
Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review
Lukas Käsmann, Maximilian Niyazi, Oliver Blanck, et al.
The Lancet. Haematology
|
May 4, 2023
European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours
Cristina Nanni, Carsten Kobe, Bettina Baeßler, et al.
Leukemia
|
October 16, 2023
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma
Michael Fuchs, Anne Sophie Jacob, Helen Kaul, et al.
The Lancet. Haematology
|
May 28, 2021
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial
Stefanie Kreissl, Helen Goergen, Ina Buehnen, et al.
The Lancet. Oncology
|
February 4, 2021
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial
Peter Borchmann, Annette Plütschow, Carsten Kobe, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
September 13, 2021
Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in Germany
David Krug, Markus Hecht, Nadja Ebert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 26, 2023
Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy
Jiaqi Fan, Anne Adams, Noëlle Sieg, et al.
Clinical Nuclear Medicine
|
January 14, 2025
The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor Relapse
Garry S Ceccon, Jan-Michael Werner, Maximilian I Ruge, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 5, 2020
Treatment Monitoring of Immunotherapy and Targeted Therapy Using <sup>18</sup>F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences
Norbert Galldiks, Diana S Y Abdulla, Matthias Scheffler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2019
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
Michael Fuchs, Helen Goergen, Carsten Kobe, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 15, 2017
Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review
Lukas Käsmann, Maximilian Niyazi, Oliver Blanck, et al.
The Lancet. Haematology
|
May 4, 2023
European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours
Cristina Nanni, Carsten Kobe, Bettina Baeßler, et al.
Leukemia
|
October 16, 2023
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma
Michael Fuchs, Anne Sophie Jacob, Helen Kaul, et al.
The Lancet. Haematology
|
May 28, 2021
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial
Stefanie Kreissl, Helen Goergen, Ina Buehnen, et al.
The Lancet. Oncology
|
February 4, 2021
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial
Peter Borchmann, Annette Plütschow, Carsten Kobe, et al.
Page
of 9